There is a newer version of the record available.

Published March 28, 2022 | Version 0

PRDX1: A Target Enabling Package

  • 1. UNC Eshelman School of Pharmacy, Chapel Hill, NC
  • 2. Centre for Medicines Discovery, University of Oxford

Description

PRDXs are thiol-dependent peroxidases which catalyse the reduction of hydrogen peroxide, peroxynitrite and alkyl hydroperoxides. Peroxiredoxin-1 (PRDX1) is involved in modulating oxidative stress and exhibits cell specific expression in brain tissue. A pathological hallmark of neurodegenerative diseases includes progressive degenerative and neuronal death, which may be induced by an imbalance of reactive oxygen species. PRDX1 may therefore affect signalling pathways involved in neuroprotection and cell death by modulating oxidative stress. Several studies have shown a link between PRDX1 expression and Alzheimer’s disease. The aim of this project is to produce TEP reagents to help further understand the biology of PRDX1 in Alzheimer’s disease.

Notes

Future versions of this TEP will contain experimental data on the PRDX1 TEP.

Files

TREAT-AD Basic TEP_PRDX1_v0.pdf

Files (457.4 kB)

Name Size Download all
md5:8c82d83fd570a86ae7f33e8c8f15a029
457.4 kB Preview Download